Inici › Obesitat › Texas › Grand Prairie
Assaigs clínics de Obesitat a Grand Prairie, TX
13 estudis de Obesitat busquen participants en centres de Grand Prairie i voltants (en un radi d'uns 30 milles). Obre un estudi per veure qui hi pot participar i com contactar amb l'equip.
Text oficial de l'estudi (anglès)
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
ReclutantFase 3
- Epic Medical Research, DeSoto · a 14 mi
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
ReclutantFase 3
- Research Site, DeSoto · a 14 mi
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
ReclutantFase 3
- Epic Medical Research - DeSoto, DeSoto · a 14 mi
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
ReclutantFase 3
- AURORA-1 Clinical Site, DeSoto · a 14 mi
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
ReclutantFase 3
- AURORA-2 Clinical Site, DeSoto · a 14 mi
- AURORA-2 Clinical Site, Waxahachie · a 26 mi
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
ReclutantFase 3
- Dallas Heart and Vascular Consultants, Duncanville · a 8 mi
AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
ReclutantFase 3
- Epic Medical Research, DeSoto · a 14 mi
AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
ReclutantFase 3
- Epic Medical Research, DeSoto · a 14 mi
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
ReclutantFase 3
- Kailera Clinical Site, DeSoto · a 14 mi
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
ReclutantFase 3
- Epic Medical Research - Red Oak, DeSoto · a 14 mi
Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
ReclutantFase 3
- Kailera Clinical Site, DeSoto · a 14 mi
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
ReclutantFase 3
- Epic Medical Research - DeSoto, DeSoto · a 14 mi
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
ReclutantFase 3
- Dallas Heart and Vascular, Duncanville · a 8 mi
Assaigs de Obesitat en altres ciutats
- Houston, TX43 estudis
- Chicago, IL41 estudis
- New York City, NY40 estudis
- San Antonio, TX40 estudis
- Washington, DC33 estudis
- Orlando, FL31 estudis
- Dallas, TX30 estudis
- Boston, MA28 estudis
- Las Vegas, NV27 estudis
- Miami, FL27 estudis
- Baltimore, MD25 estudis
- Jacksonville, FL25 estudis
Altres estudis a Grand Prairie
- Sobrepès11 estudis
- Trastorn depressiu major11 estudis
- Depressió8 estudis
- Esquizofrènia8 estudis
- Malaltia hepàtica esteatòtica5 estudis
- Insuficiència cardíaca4 estudis
- EPOC3 estudis
- Trastorns de l'estat d'ànim3 estudis
- Diabetis tipus 23 estudis
- Trastorns psicòtics3 estudis
- Migranya3 estudis
De ClinicalTrials.gov, dades recuperades el 5 d’oct. 2026. Cada estudi estableix els seus propis criteris d'elegibilitat; l'equip de l'estudi decideix qui hi pot participar.